Yevgeniy Feyman, Manhattan Institute

Yevgeniy Feyman

Manhattan Institute

Boston, MA, United States

Contact Yevgeniy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • Manhattan Institute
  • Economics21
  • Forbes

Past articles by Yevgeniy:

Tinker, Scrap, or Start Over: Let States Decide How to Fix Health Care

With Republican efforts to repeal and replace the Affordable Care Act at an impasse, the Senate HELP Committee, led by Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.), has held two weeks of bipartisan hearings on how to help states stabilize the individual market... → Read More

How to Expand Healthcare Choice for Consumers

States are just beginning to seriously explore the potential of 1332 waivers. The limited engagement to date reflects both the highly partisan nature of the debate around the ACA and uncertainty about the future and scope of funding sources that currently flow through the ACA exchanges. Congress and the Trump Administration should address both issues simultaneously. → Read More

How Congress Should Clarify and Expand the ACA's State Innovation Waivers

States are just beginning to seriously explore the potential of 1332 waivers. → Read More

A Tax Reform President Trump Should Like, and You Should Too

Ongoing efforts to repeal and replace the Affordable Care Act embody a rare opportunity to address not only problems that have arisen under the ACA, but other severe health policy problems that long preceded it. One of these is the distorted tax treatment of employer-provided insurance, through... → Read More

The Burgeoning "Yelpification" of Health Care: Foundations Help Consumers Hold a Scale and a Mirror to the Health Care System

From flashy tech start-ups in Silicon Valley to modernized insurers in New York, everyone wants to “disrupt” health care. In practice, this is immensely more challenging than it sounds. Electronic health records (EHRs), more than a decade ago, were expected to revolutionize how health... → Read More

How Yelping Doctors Is Improving Americans' Health Care

Aggregating social media reviews—the wisdom of crowds—has turned into a powerful new tool for consumers, helping them to find trusted services quickly and efficiently. It’s also allowed new businesses to rapidly reach their intended market and tweak their services based on consumers’... → Read More

Yelp for Health: Using the Wisdom of Crowds to Find High-Quality Hospitals

Online tools like ZocDoc, HealthGrades, and Yelp have become popular among people who search for information about physicians and hospitals. Yelp, one of the most widely used platforms, allows patients to rate health-care providers through a five-star rating system that can include narrative text reviews. → Read More

Health Care Disagreement Is an Opportunity for Trump

In a transparent program with streamlined waivers, both Red and Blue states could experiment with more innovative programs for the poor. → Read More

How to Save and Fix Medicare

Medicare — our socialized health-insurance scheme for the elderly and disabled — covers 55 million people. That's 17% of the American population, or roughly the population of England. The program accounts for 15% of the federal budget and 3% of our economy. → Read More

Repeal & Replace: Missing the Medicare Forest for the Obamacare Trees

The Trump Administration has promised to deliver to the American people a healthcare plan that is, in President Trump’s own words, “much less expensive and far better” than Obamacare. But while Obamacare is expected to spend over $900 billion from 2018 to 2027, focusing solely on the... → Read More

Three Reforms That Can Help Balance Medicare Finances

Topping the health-care agenda of the Trump administration and Congress is the repeal and replacement of the Affordable Care Act. Still, it would be a mistake to ignore Medicare, the nation’s single largest health-care entitlement. → Read More

Is Pharmaceutical Productivity In Decline? Maybe Not

The popular trope of the past decade (and then some) has been that pharmaceutical companies’ productivity is lagging – that R&D spending is becoming ever-less useful. This phenomenon has become so commonly accepted that it’s been coined “Eroom’s Law;” Moore’s Law in reverse. Productivity has sunk so law, the story [...] → Read More

No Inversion Is Not Unpatriotic. Yes We Need Corporate Tax Reform

Several recent high profile deals have directed media and public attention to the topic of “tax inversion,” whereby a company moves its headquarters overseas (usually in an M&A deal) in order to reduce its tax burden. According to the Wall Street Journal (citing Thomson Reuters) there have been 22 such [...] → Read More

Fix the FDA, Fix Patents, Save Lives

Bringing life-saving drugs to market isn’t cheap – the capitalized cost of bringing a typical drug to market is around $1.2 billion and continues to grow every year. And thanks in no small part to heavy-handed FDA regulations, this cost is slated to keep growing, especially for new, highly targeted [...] → Read More

Perspectives On Obamacare's First Year Enrollment

The day that many health policy wonks have been waiting for has come: Obamacare's first open–enrollment period has officially ended on April 15, 2014. Wasting little time, the Department of Health and Human Services (HHS) has released the last of its first–year enrollment reports. The update from HHS contains some good news, and some not–so–good news. Overall, it appears highly unlikely that the healthcare… → Read More

Reforming The FDA Can Save $900 Million Annually And Generate $4 Trillion In Annual Social Value

Without a doubt, one of the most important American regulatory bodies is the FDA. As the agency charged with ensuring the safety of everything from the protein shake you drank after the gym to the ibuprofen you take the next day because you forgot to stretch, its responsibilities affect every [...] → Read More

Repealing The Employer Mandate Can Cut The Deficit (And Then Some)

Some people say that bipartisanship is dead. But if rumblings in the House are to be believed, cooperation on Obamacare may yet be possible. The “Save American Workers Act of 2014,” which passed the House 248-179 (with 18 Democrats voting in favor) amends the ACA to redefine “full-time employees” as [...] → Read More

FDA And Meningitis B: Picking Winners And Losers

The recent death of a Drexel University student due to a rare meningitis B strain is an unquestionable tragedy; one that is made all the more tragic because two vaccines for this strain already exist (one of which has been approved by overseas regulators). Unfortunately, the FDA has been dragging [...] → Read More

Obamacare Still Isn't Failing, But It's Not Succeeding

With Obamacare’s 2014 open enrollment period approaching its end (barring another legally dubious delay or extension), the Department of Health and Human Services (HHS) has released what will be the second-to-last report on exchange enrollment for 2014. Let’s start with the good news. The exchanges have enrolled some 4.2 million people [...] → Read More